https://www.businesswire.com/news/home/20260323166862/en/Aurinia-Announces-Management-Transition
Aurinia Announces Management Transition
Aurinia Announces Management Transition
auriniaannouncesmanagementtransition
https://www.biospace.com/aurinia-announces-closing-of-us-7-million-private-placement
Aurinia Announces Closing Of US$7 Million Private Placement - BioSpace
of usprivate placementauriniaannouncesclosing
https://www.biospace.com/aurinia-announces-preliminary-topline-data-from-its-open-label-aurion-study-in-lupus-nephritis
Aurinia Announces Preliminary Topline Data From Its Open Label Aurion Study In Lupus Nephritis -...
https://investingnews.com/aurinia-pharmaceuticals-to-present-at-upcoming-41st-annual-j-p-morgan-healthcare-conference/
Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference | INN
Jan 4, 2023 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, is scheduled...
https://www.businesswire.com/news/home/20240227383351/en/Aurinia-to-Participate-in-Upcoming-Investor-Healthcare-Conferences
Aurinia to Participate in Upcoming Investor Healthcare Conferences
Aurinia to Participate in Upcoming Investor Healthcare Conferences
to participateauriniaupcominginvestorhealthcare
https://www.auriniapharma.com/
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical...
auriniapharmaceuticalsinc
https://finviz.com/news/54498/aurinia-pharmaceuticals-auph-surpasses-q1-earnings-and-revenue-estimates
Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates
Stock screener for investors and traders, financial visualizations.
auriniapharmaceuticalsq1earningsrevenue
https://investingnews.com/news/biotech-investing/aurinia-announces-outcome-of-audrey-clinical-trial-in-dry-eye-syndrome/
Aurinia Announces Outcome of AUDREY Clinical Trial in Dry Eye Syndrome | INN
Aug 8, 2023 - - Aurinia to host conference call today at 4:30 p.m. EST - Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage...
dry eye syndromeclinical trial
https://investingnews.com/aurinia-pharmaceuticals-reports-financial-results-for-the-three-and-twelve-months-ended-december-31-2025-and-provides-update-on-recent-business-progress/
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December...
Feb 26, 2026 - Full Year 2025 LUPKYNIS Sales Grew 25% Announces LUPKYNIS Sales Guidance for 2026 of $305 Million to $315 Million Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)...
https://investingnews.com/aurinia-pharmaceuticals-to-acquire-kezar-life-sciences-for-6-955-in-cash-per-share-plus-a-contingent-value-right/
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a...
Mar 30, 2026 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high...
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-auph/aurinia-pharmaceuticals/news/aurinia-pharmaceuticals-incs-nasdaqauph-ceo-will-probably-fi
Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise...
Key Insights Aurinia Pharmaceuticals to hold its Annual General Meeting on 15th of May CEO Peter Greenleaf's total...
https://www.auriniacareers.com/
Careers | Aurinia Careers
careersaurinia
https://www.bfn.de/artenportraits/euphydryas-aurinia
Euphydryas aurinia | BFN
euphydryas auriniabfn
https://www.correos.es/es/es/particulares/filatelia/productos-filatelicos/matasellos/primer-dia-espana/2010/fauna-mariposas-euphydiras-aurinia-zerynthia-rumina
FAUNA -MARIPOSAS EUPHYDIRAS AURINIA-ZERYNTHIA RUMINA
faunamariposasauriniazerynthiarumina
https://theorg.com/org/aurinia-pharmaceuticals?person=michelle-bolduc
Aurinia Pharmaceuticals | The Org
Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity.
auriniapharmaceuticals
https://www.biospace.com/aurinia-pharmaceuticals-to-present-at-the-21st-annual-h-c-wainwright-global-investment-conference
Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference...
Sep 6, 2019 - Aurinia Pharmaceuticals Inc. announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will present a corporate overview at the 21st...
https://investingnews.com/aurinia-pharmaceuticals-announces-presentations-at-the-2022-national-kidney-foundation-spring-clinical-meetings/
Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring...
Apr 4, 2022 - Presentations include new analyses of AURORA 1 and details on the ENLIGHT-LN registry Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), a...
national kidney foundationauriniapharmaceuticalsannouncespresentations
https://investingnews.com/auph-shareholder-alert-jakubowitz-law-reminds-aurinia-pharmaceuticals-inc-shareholders-of-a-lead-plaintiff-deadline-of-june-14-2022/
AUPH SHAREHOLDER ALERT: Jakubowitz Law Reminds Aurinia Pharmaceuticals Inc. Shareholders of a Lead...
Apr 29, 2022 - - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)....
https://www.businesswire.com/news/home/20231102070232/en/Aurinia-Pharmaceuticals-Reports-Third-Quarter-and-Nine-Months-2023-Financial-and-Operational-Results
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
AURINIA PHARMACEUTICALS REPORTS THIRD QUARTER AND NINE MONTHS 2023 FINANCIAL AND OPERATIONAL RESULTS
third quarter
https://investingnews.com/aurinia-pharmaceuticals-inc-securities-fraud-class-action-lawsuit-pending-contact-levi-korsinsky-before-june-14-2022-to-discuss-your-rights-auph/
Aurinia Pharmaceuticals Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &...
class action lawsuitsecurities fraudauriniapharmaceuticalsinc
https://investingnews.com/ongoing-investigation-alert-the-schall-law-firm-encourages-investors-in-aurinia-pharmaceuticals-inc-with-losses-of-100000-to-contact-the-firm/
ONGOING INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals...
Mar 18, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofAurinia Pharmaceuticals...
law firm
https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-motus-gi-aurinia-pharmaceuticals-aptose-biosciences-vaxart-or-atossa-therapeutics-301281193.html
Thinking about buying stock in Motus GI, Aurinia Pharmaceuticals, Aptose Biosciences, Vaxart, or...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MOTS, AUPH, APTO, VXRT, and ATOS. To see how InvestorsObserver's proprietary scoring...
https://www.biospace.com/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 -...
Apr 24, 2023 - Aurinia Pharmaceuticals Inc. announced that it will release financial and operational results for the first quarter of 2023, on Thursday, May 4, 2023, before...
https://www.auriniaconsulting.net/
Aurinia Consulting | Business Systems Solutions
Aurinia Consulting provides enterprise ERP software consulting for businesses in the manufacturing and distribution industries.
consulting businessauriniasystemssolutions
https://finviz.com/quote?t=AUPH
AUPH - Aurinia Pharmaceuticals Inc Stock Price and Quote
AUPH - Aurinia Pharmaceuticals Inc - Stock screener for investors and traders, financial visualizations.
stock priceauriniapharmaceuticalsincquote
https://www.fxempire.com/stocks/auph/advanced-chart
Aurinia Pharmaceuticals Inc (AUPH) Stock Live Chart | FXEmpire
View live Aurinia Pharmaceuticals Inc stock chart to track the latest price changes. AUPH price chart, real-time data, technical analysis tools, and historical...
live chartauriniapharmaceuticalsincstock
https://www.fool.com/investing/2017/07/14/is-aurinia-pharmaceuticals-management-its-best-as.aspx
Is Aurinia Pharmaceuticals' Management Its Best Asset? | The Motley Fool
Jul 15, 2017 - The company's C-suite is loaded with experienced industry veterans, and that could put it in a perfect position to successfully develop its lead drug for lupus...
the motleyauriniapharmaceuticalsmanagementbest
https://finviz.com/quote?t=AUPH&ta=1&p=d
AUPH - Aurinia Pharmaceuticals Inc Stock Price and Quote
AUPH - Aurinia Pharmaceuticals Inc - Stock screener for investors and traders, financial visualizations.
stock priceauriniapharmaceuticalsincquote
https://investingnews.com/aurinia-alert-bragar-eagel-squire-p-c-announces-that-a-class-action-lawsuit-has-been-filed-against-aurinia-pharmaceuticals-inc-and-encourages-investors-to-contact-the-firm/
AURINIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed...
https://investingnews.com/aurinia-pharmaceuticals-reports-financial-results-for-the-three-months-ended-march-31-2026-and-provides-update-on-recent-business-progress/
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and...
May 7, 2026 - Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three months ended March 31, 2026 and provided an update on recent...
https://www.businesswire.com/news/home/20230517005675/en/Aurinia-Announces-2023-Annual-General-Meeting-Results
Aurinia Announces 2023 Annual General Meeting Results
Aurinia Announces 2023 Annual General Meeting Results
2023 annual general meetingauriniaannouncesresults
https://www.biospace.com/aurinia-prices-us-166-7-million-public-offering-of-common-shares
Aurinia Prices US$166.7 Million Public Offering of Common Shares - BioSpace
Dec 10, 2019 - Aurinia Pharmaceuticals Inc., a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, announced the pricing...
us 166
https://capital.com/en-eu/markets/shares/aurinia-pharmaceuticals-inc-share-price
Aurinia Pharmaceuticals Inc. (AUPH) Stock Price Quote Today & Current Price Chart | Capital.com EU
https://investingnews.com/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-aurinia-pharmaceuticals-inc-auph/
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurinia...
Mar 3, 2022 - Pomerantz LLP is investigating claims on behalf of investors of Aurinia Pharmaceuticals Inc . ("Aurinia" or the "Company") (NASDAQ: AUPH). Such investors are...
shareholder alertlaw firm
https://investingnews.com/news/biotech-investing/aurinia-reports-third-quarter-2020-financial-results-and-recent-operational-highlights/
Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights | INN
third quarter2020 financial
https://www.rhs.org.uk/plants/112796/aurinia-saxatilis-goldkugel/details
Aurinia saxatilis 'Goldkugel' | Alpine Rockery/RHS
aurinia saxatilisalpinerockeryrhs